These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 8888167)

  • 1. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
    Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
    Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems.
    Preiser W; Szép NI; Lang D; Doerr HW; Rabenau HF
    Med Microbiol Immunol; 2001 Dec; 190(3):121-7. PubMed ID: 11827200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
    Lin SF; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
    J Virol; 1997 Apr; 71(4):3069-76. PubMed ID: 9060668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
    Kedes DH; Lagunoff M; Renne R; Ganem D
    J Clin Invest; 1997 Nov; 100(10):2606-10. PubMed ID: 9366576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
    Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
    Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.
    Katano H; Iwasaki T; Baba N; Terai M; Mori S; Iwamoto A; Kurata T; Sata T
    J Virol; 2000 Apr; 74(8):3478-85. PubMed ID: 10729121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy.
    Calabrò ML; Sheldon J; Favero A; Simpson GR; Fiore JR; Gomes E; Angarano G; Chieco-Bianchi L; Schulz TF
    J Hum Virol; 1998; 1(3):207-13. PubMed ID: 10195244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in various populations in Cuba.
    Kourí V; Eng SM; Rodríguez ME; Resik S; Orraca O; Moore PS; Chang Y
    Rev Panam Salud Publica; 2004 May; 15(5):320-5. PubMed ID: 15231079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.
    Schatz O; Monini P; Bugarini R; Neipel F; Schulz TF; Andreoni M; Erb P; Eggers M; Haas J; Buttò S; Lukwiya M; Bogner JR; Yaguboglu S; Sheldon J; Sarmati L; Goebel FD; Hintermaier R; Enders G; Regamey N; Wernli M; Stürzl M; Rezza G; Ensoli B
    J Med Virol; 2001 Sep; 65(1):123-32. PubMed ID: 11505454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome.
    Kellam P; Boshoff C; Whitby D; Matthews S; Weiss RA; Talbot SJ
    J Hum Virol; 1997; 1(1):19-29. PubMed ID: 10195227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.
    Davis DA; Humphrey RW; Newcomb FM; O'Brien TR; Goedert JJ; Straus SE; Yarchoan R
    J Infect Dis; 1997 May; 175(5):1071-9. PubMed ID: 9129068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: variable frequencies found in a multicenter serological study.
    Enbom M; Sheldon J; Lennette E; Schulz T; Ablashi DV; Neipel F; Biberfeld P; Carlberg H; Ljungman P; Nilsson A; Söderström T; Wadström J; Linde A
    J Med Virol; 2000 Dec; 62(4):498-504. PubMed ID: 11074479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma.
    André S; Schatz O; Bogner JR; Zeichhardt H; Stöffler-Meilicke M; Jahn HU; Ullrich R; Sonntag AK; Kehm R; Haas J
    J Mol Med (Berl); 1997 Feb; 75(2):145-52. PubMed ID: 9083932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of infection with human herpesvirus 8/Kaposi's sarcoma herpesvirus in rural South Africa.
    Wilkinson D; Sheldon J; Gilks CF; Schulz TF
    S Afr Med J; 1999 May; 89(5):554-7. PubMed ID: 10416461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chimpanzee rhadinovirus sequence related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8: increased detection after HIV-1 infection in the absence of disease.
    Greensill J; Sheldon JA; Murthy KK; Bessonette JS; Beer BE; Schulz TF
    AIDS; 2000 Dec; 14(17):F129-35. PubMed ID: 11125908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of Kaposi's sarcoma-associated herpesvirus serological assays using clinically and serologically defined reference standards and latent class analysis.
    Nascimento MC; de Souza VA; Sumita LM; Freire W; Munoz F; Kim J; Pannuti CS; Mayaud P
    J Clin Microbiol; 2007 Mar; 45(3):715-20. PubMed ID: 17182752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay.
    Chatlynne LG; Lapps W; Handy M; Huang YQ; Masood R; Hamilton AS; Said JW; Koeffler HP; Kaplan MH; Friedman-Kien A; Gill PS; Whitman JE; Ablashi DV
    Blood; 1998 Jul; 92(1):53-8. PubMed ID: 9639499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.